|1.||Ichihara, Gaku: 2 articles (02/2013 - 01/2004)|
|2.||Takeuchi, Yasuhiro: 2 articles (01/2006 - 01/2004)|
|3.||Wang, Yanrang: 1 article (12/2014)|
|4.||Zhang, Ming: 1 article (12/2014)|
|5.||Fang, Zhonghua: 1 article (12/2014)|
|6.||Yang, Deyi: 1 article (12/2014)|
|7.||Zhang, Yingyi: 1 article (12/2014)|
|8.||Miao, Rongming: 1 article (12/2014)|
|9.||National Toxicology Program: 1 article (09/2013)|
|10.||Subramanian, Kaviarasan: 1 article (02/2013)|
09/01/2013 - "From this assessment, the NTP recommended that 1 bromopropane be listed as reasonably anticipated to be a human carcinogen in the RoC based on sufficient evidence from studies in experimental animals, which found inhalation exposure to 1-bromopropane caused skin tumors in male rats, large intestine tumors in female and male rats, and lung tumors in female mice. "
09/01/2013 - "The monograph consists of two components: (Part 1) the cancer evaluation, which reviews the relevant scientific information, assesses its quality, applies the RoC listing criteria to the scientific information, and provides the NTP recommendation for listing status for 1 bromopropane in the RoC, and (Part 2) the substance profile proposed for the RoC, containing the NTP's listing status recommendation, a summary of the scientific evidence considered key to reaching that decision, and data on properties, use, production, exposure, and Federal regulations and guidelines to reduce exposure to 1-bromopropane. "
01/01/2004 - "Frequent symptoms reported by workers exposed to 1-bromopropane were nose, throat, and eyes irritation or malaise and/or headache. "
01/01/2007 - "This report supports the growing recognition of 1-bromopropane neurotoxicity in humans consisting most commonly of headache, nausea, and subacute spastic paraparesis with distal sensory loss. "
|5.||Peripheral Nervous System Diseases (PNS Diseases)
|1.||Hazardous Substances (Hazardous Materials)
|3.||formal glycol (dioxolane)